Magnesium Recall: FDA Announces Popular Supplement’s Removal
Key Points:
- Magnesium supplements gained popularity during the pandemic, with different forms serving various functions such as promoting sleep, acting as laxatives, relieving migraines, and relaxing muscles.
- The FDA announced a recall on June 19 for nearly 14,000 bottles of Adndale magnesium glycinate gummies due to the presence of undeclared melatonin, which could intensify sleep effects.
- The recalled product, manufactured by Dkiru LLC in Dublin, Ireland, includes specific lot numbers and expiration dates, and is classified as a Class II recall, indicating potential temporary or reversible health risks.
- Excessive magnesium intake can cause gastrointestinal issues, low blood pressure, fatigue, and kidney problems, with recommended daily allowances being 400 mg for men and 320 mg for women.